Glenmark Life Sciences IPO- Fundamental Analysis

Glenmark Life Sciences IPO- Fundamental Analysis Financial Highlights of Glenmark Life Sciences IPO Increase in sales attributed to a rise of 21.73% in the total revenues (Rs 1885.98 crore) for FY21 as against Rs 1549.31 […]